Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SGE

When a company has over a $123M inflow of cash, essentially no debt

Put like that it's obvious, but excludes the debentures and warrants, Fish settlement, etc., etc.. Notwithstanding the costs in generating licensing revenue.

But, that wouldn't fit, would it?

.

.

.

Be well

Share
New Message
Please login to post a reply